Key result
The MAPEC study is a prospective study designed to investigate whether chronotherapy of antihypertensive medications reduces cardiovascular risk, with no results reported in this abstract.
Why the study?
Does chronotherapy of antihypertensive medication reduce cardiovascular, cerebrovascular, and renal risk in diurnally active adults?
Population
3,000 diurnally active men and women ≥18 years of age
Design
Other
Authors
Loading...
Does not yet inform antihypertensive timing; leaves open whether chronotherapy reduces cardiovascular risk in prospective cohorts.
Does chronotherapy of antihypertensive medication reduce cardiovascular, cerebrovascular, and renal risk in diurnally active adults?
The MAPEC study is designed to evaluate whether chronotherapy of antihypertensive medications based on 24-hour ambulatory blood pressure monitoring reduces cardiovascular, cerebrovascular, and renal events.
Hermida et al. (2007) studied Hypertension / Cardiovascular risk (n=3,000). Chronotherapy (timed administration of antihypertensive medication) was evaluated on Cardiovascular, cerebrovascular, and renal risk. The MAPEC study is a prospective study designed to investigate whether chronotherapy of antihypertensive medications reduces cardiovascular risk, with no results reported in this abstract.